Pharma

PKG Health's movement disorder algorithms and digital endpoints will be integrated into Empatica’s AI-enabled health monitoring wearables.

HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.

Thanks to the deal, Pfizer will avoid upcoming U.S. tariffs on overseas-made drugs for three years by offering discounted medications directly to American consumers.

At Healthcare 2030 in Washington, D.C., panelists highlighted debated challenges around interoperability, FHIR adoption and the need for industry-wide standards.

At an event in Washington, D.C., on Monday, DiMe released a thesis with what it says are four impact areas that are vital to pursue in digital medicine in the next five years.

The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.

The company plans to expand partnerships with health plans and employers to provide more individuals with digital twin technology designed to improve metabolic health.

Define Ventures surveyed more than 40 executives from 15 of the top 20 pharma companies on the readiness of AI in healthcare, says Carolyn Magill, venture partner at the VC firm. A vast majority said AI is a priority in healthcare.

In a panel discussion, experts emphasized that AI must align with clinical workflows, reduce cognitive load, and support – not replace – clinicians.

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.